Benzoic Acid

Benzoic Acid

SCHEMBL2196273

C[N+](C)(C)CCO.O=C([O-])c1ccccc1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D

The experimentally established mechanism targets of Benzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.57
CA4 P22748 1/20 0.57
LMNA P02545 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
CYP3A4 P08684 1/20 0.43
SLC5A7 Q9GZV3 1/20 0.43
CES2 O00748 3/20 0.41
CES1 P23141 3/20 0.41
CHRM2 P08172 2/20 0.40
CHRM4 P08173 2/20 0.40
CHRM1 P11229 2/20 0.40
CHRM3 P20309 2/20 0.40
ALPL P05186 1/20 0.40
POLB P06746 1/20 0.40
ALPG P10696 1/20 0.40
TSHR P16473 1/20 0.39
ALDH1A1 P00352 1/20 0.38
USP2 O75604 1/20 0.38
EDNRB P24530 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoic Acid SCHEMBL16106190 0.92 CA2 (0.53) CA2CA4LMNAMEN1KMT2A
Benzoic Acid SCHEMBL20919826 0.91 CA2 (0.47) CA2CA4LMNAMEN1KMT2A
Terephthalic Acid SCHEMBL30148140 0.90 MEN1 (0.48) CA2CA4LMNAMEN1KMT2A
Isophthalic Acid SCHEMBL30148147 0.87 KMT2A (0.41) CA2CA4LMNAMEN1KMT2A
Benzoic Acid SCHEMBL31683095 0.85 CA2 (0.57) CA2CA4LMNAMEN1KMT2A
Benzoic Acid SCHEMBL2196278 0.85 TSHR (0.56) LMNAMEN1KMT2ACYP3A4SLC5A7
Benzil SCHEMBL28412627 0.85 CES2 (0.56) LMNAMEN1KMT2ACYP3A4SLC5A7
Benzoic Acid SCHEMBL25434241 0.83 TSHR (0.54) LMNAMEN1KMT2ACYP3A4SLC5A7
Choline SCHEMBL10892688 0.83 LMNA (0.44) LMNAMEN1KMT2ACYP3A4SLC5A7
Phthalic Acid SCHEMBL7100569 0.83 MEN1 (0.44) CA2CA4LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108048421-A The method that transfructosylase catalytic efficiency and stability are improved using choline eutectic solvent 天津科技大学 2018-05-18 CN claimed
US-6462005-B1 AQUEOUS SOLUTION CONTAINING A QUARTERNARY AMMONIUM SALT, A FLUORO COMPOUND AND OPTIONALLY AN ORGANIC SOLVENT; PROTECTING DEPOSITION FILM TO BE REMOVED; NO CORROSION OF CONDUCTIVE LAYER BEING DECONTAMINATED TEXAS INSTRUMENTS INCORPORATED 2002-10-08 US claimed
US-5972862-A COMPRISING A FLUORINE-CONTAINING COMPOUND, A WATER-SOLUBLE OR WATER-MISCIBLE ORGANIC SOLVENT, AN ORGANIC ACID, AND A QUATERNARY AMMONIUM SALT MITSUBISHI GAS CHEMICAL (JP) 1999-10-26 US claimed
WO-2026106933-A1 BIOFOAM AND RIGID BIOMATERIAL FORMULATIONS AND PROCESSES OF USING THE SAME TO PRODUCE BIODEGRADABLE PRODUCTS BIOCHOSEN, INC. (US) 2026-05-21 WO disclosed
US-20250231492-A1 MANUFACTURE OF INTEGRATED CIRUIT USING POSITIVE TONE PHOTOPATTERNABLE DIELECTRIC INCLUDING HIGH SILICON CONTENT POLYSILSESQUIOXANE SUNTIFIC MATERIALS (WEIFANG)., LTD. (CN) 2025-07-17 US disclosed
CN-119816784-A Fabrication of integrated circuits using positive photo-patternable dielectrics comprising high silicon content polysilsesquioxanes 潍坊星泰克微电子材料有限公司 2025-04-11 CN disclosed
EP-4508495-A1 MANUFACTURE OF INTEGRATED CIRUIT USING POSITIVE TONE PHOTOPATTERNABLE DIELECTRIC INCLUDING HIGH SILICON CONTENT POLYSILSESQUIOXANE Suntific Materials (Weifang), Ltd. (CN) 2025-02-19 EP disclosed
WO-2025000535-A1 MANUFACTURE OF INTEGRATED CIRUIT USING POSITIVE TONE PHOTOPATTERNABLE DIELECTRIC INCLUDING HIGH SILICON CONTENT POLYSILSESQUIOXANE SUNTIFIC MATERIALS (WEIFANG), LTD. (CN) 2025-01-02 WO disclosed
EP-4333891-A1 IONIC LIQUID FORMULATIONS FOR TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES I2O Therapeutics, Inc. (US) 2024-03-13 EP disclosed
CN-117642180-A Ionic liquid formulations for the treatment of inflammatory and autoimmune diseases I2O治疗公司 2024-03-01 CN disclosed
US-20240067716-A1 IONIC LIQUID FORMULATIONS FOR TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES I2O THERAPEUTICS, INC. 2024-02-29 US disclosed
US-6462005-B1 AQUEOUS SOLUTION CONTAINING A QUARTERNARY AMMONIUM SALT, A FLUORO COMPOUND AND OPTIONALLY AN ORGANIC SOLVENT; PROTECTING DEPOSITION FILM TO BE REMOVED; NO CORROSION OF CONDUCTIVE LAYER BEING DECONTAMINATED TEXAS INSTRUMENTS INCORPORATED 2002-10-08 US disclosed
US-6265309-B1 Cleaning agent for use in producing semiconductor devices and process for producing semiconductor devices using the same MITSUBISHI GAS CHEMICALS CO., INC. (JP) 2001-07-24 US disclosed
EP-0662705-B1 Cleaning agent for semiconductor device and method for manufacturing semiconductor device MITSUBISHI GAS CHEMICAL CO (JP) 2000-08-23 EP disclosed
US-5972862-A COMPRISING A FLUORINE-CONTAINING COMPOUND, A WATER-SOLUBLE OR WATER-MISCIBLE ORGANIC SOLVENT, AN ORGANIC ACID, AND A QUATERNARY AMMONIUM SALT MITSUBISHI GAS CHEMICAL (JP) 1999-10-26 US disclosed
EP-0827188-A2 Cleaning liquid for producing semiconductor device and process for producing semiconductor device using same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1998-03-04 EP disclosed
EP-0662705-A2 Cleaning agent for semiconductor device and method for manufacturing semiconductor device MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1995-07-12 EP disclosed
US-4340698-A CHOLINE COMPOUND CATALYST INTERNATIONALE OCTROOI MAATSCHAPPIJ "OCTROPA" B.V. (NL) 1982-07-20 US disclosed
EP-0010805-B1 POWDER COATING, PROCESS FOR THE PREPARATION THEREOF AND ARTICLES COATED THEREWITH UNILEVER N.V. (NL) 1982-02-10 EP disclosed
EP-0010805-A1 Powder coating, process for the preparation thereof and articles coated therewith UNILEVER N.V. (NL) 1980-05-14 EP disclosed